Solana Company Class A Common Stock (DE) (HSDT) is a publicly traded Healthcare sector company. As of May 21, 2026, HSDT trades at $2.20 with a market cap of $127.28M and a P/E ratio of -1.26. HSDT moved +7.18% today. Year to date, HSDT is -31.04%; over the trailing twelve months it is -98.99%. Its 52-week range spans $1.59 to $1,200.00. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces HSDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Solana Company Q1 Revenue Hits $3.6M With $99.8M Net Loss: Solana Company generated $3.6 million revenue in Q1 2026, up from $49,000 in Q1 2025, driven by $3.4 million in staking rewards and executed $3.5 million share repurchases. It reported a $99.8 million net loss (–$1.30/share) due to $89.2 million unrealized digital asset losses and $7.0 million realized losses.
| Metric | Value |
|---|---|
| Price | $2.20 |
| Market Cap | $127.28M |
| P/E Ratio | -1.26 |
| EPS | $-1.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,200.00 |
| 52-Week Low | $1.59 |
| Volume | 440 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.02M |
| Net Income | $-40.89M |
| Gross Margin | 91.69% |
2 analysts cover HSDT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.